These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 4738466)

  • 1. [Inhibitory effect of 4-(2-carboxyethyl) phenyl trans-4-aminomethyl cyclohexane carboxylate hydrochloride on fibrinolysis, esterolysis and proteolysis and its degradation by serum esterases: in vitro study].
    Nagamatsu Y; Matsumoto M; Yamamoto J; Okamoto U
    Nihon Ketsueki Gakkai Zasshi; 1973 Apr; 36(2):150-8. PubMed ID: 4738466
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inhibition of plasmin system by 4-(2-carboxyethyl) phenyl-trans-4-aminomethyl cyclohexane carboxylate hydrochloride (DV 1006) (AUTHOR'S TRANSL)].
    Maki M
    Rinsho Ketsueki; 1972 Feb; 13(1):30-7. PubMed ID: 4281839
    [No Abstract]   [Full Text] [Related]  

  • 3. A new broad spectrum inhibitor of esteroproteases, 4-(2-carboxyethyl) phenyl-trans-4-aminomethyl cyclohexane carboxylate hydrochloride (DV 1006).
    Maki M; Sasaki K
    Tohoku J Exp Med; 1972 Mar; 106(3):233-48. PubMed ID: 4261023
    [No Abstract]   [Full Text] [Related]  

  • 4. Passage of tranexamic acid (AMCA) to semen in man and its effect on the fibrinolytic activity and on migration of spermatozoa.
    Liedholm P; Astedt B; Kullander S
    Fertil Steril; 1973 Jul; 24(7):517-20. PubMed ID: 4715226
    [No Abstract]   [Full Text] [Related]  

  • 5. On the heterogeneity of activity by various types of plasmins and the spectra of inhibition of some plasmin inhibitors.
    Ambrus CM; Ambrus JL; Lassman HB; Mink IB
    Res Commun Chem Pathol Pharmacol; 1970 Jan; 1(1):67-85. PubMed ID: 4257701
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the significance of secondary fibrinolysis in experimental DIC (author's transl)].
    Goto H
    Nihon Seirigaku Zasshi; 1973 Jun; 35(6):295-306. PubMed ID: 4270923
    [No Abstract]   [Full Text] [Related]  

  • 7. On the effects of tranexamic acid and its isobenzedrine ester on plasminogen activation and streptokinase induced fibrinolysis.
    Baldacci M; Catalani R; Bartoli C; Del Corso A; Tozzi MG; Mura U
    Boll Soc Ital Biol Sper; 1989 Jun; 65(6):521-8. PubMed ID: 2611013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the mechanism of action of synthetic antifibrinolytics. A comparison with the action of derivatives of benzamidine on the fibrinolytic process.
    Landmann H
    Thromb Diath Haemorrh; 1973 May; 29(2):253-75. PubMed ID: 4271586
    [No Abstract]   [Full Text] [Related]  

  • 9. [Trans-4-(aminomethyl)-cyclohexanecarbonic acid in the therapy of chronic fibrinolytic syndromes].
    Bile G; De Biasi R; Chiariello L
    Clin Ter; 1970 Jan; 52(2):115-44. PubMed ID: 5525591
    [No Abstract]   [Full Text] [Related]  

  • 10. Tranexamic acid and fibrinolytic activity of the vessel wall.
    Astedt B; Liedholm P
    Experientia; 1974 Jul; 30(7):776-7. PubMed ID: 4847668
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of DL-trans-2-dimethylamino-1-phenyl-cyclohex-3-ene-trans-carbonic acid ethylester hydrochloride on human pulmonary circulation in the acute test].
    Degenring FH; Radeck R
    Arzneimittelforschung; 1972 Mar; 22(3):580-2. PubMed ID: 5067933
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitative assessment of fibrinolysis on isolated glomeruli.
    Sraer JD; Boelaert J; Mimoune O; Morel-Maroger L; Hornych H
    Kidney Int; 1973 Nov; 4(5):350-2. PubMed ID: 4762582
    [No Abstract]   [Full Text] [Related]  

  • 13. Medicinal chemical studies on antiplasmin drugs. 4. Chemical modification of trans-4-aminomethylcyclohexanecarboxylic acid and its effect on antiplasmin activity.
    Okano A; Inaoka M; Funabashi S; Iwamoto M; Isoda S
    J Med Chem; 1972 Mar; 15(3):247-55. PubMed ID: 5059209
    [No Abstract]   [Full Text] [Related]  

  • 14. Fibrinogen degradation products in plasma following induced hyperfibrinolysis.
    Chek JB; Panchenko NI
    East Afr Med J; 2000 Apr; 77(4):217-20. PubMed ID: 12858907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of trans-4-aminomethylcyclohexane carboxylic acid as an antifibrinolytic agent on arterial wall and experimental atherosclerotic lesions in rabbits.
    Kato N; Morimatsu M; Tanaka K; Horie A
    Thromb Diath Haemorrh; 1970 Oct; 24(1):85-99. PubMed ID: 5483976
    [No Abstract]   [Full Text] [Related]  

  • 16. Tranexamic acid and gastric fibrinolysis in the rat.
    Stenberg B; Risberg B; Peterson HI
    Thromb Haemost; 1980 Feb; 42(5):1425-8. PubMed ID: 7368148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of amino-methyl-cyclohexane-carboxylic acid (AMCHA) in activated hemostasis].
    Pfeifer GW; Dietz M
    Zentralbl Gynakol; 1969 Oct; 91(40):1292-5. PubMed ID: 5308573
    [No Abstract]   [Full Text] [Related]  

  • 18. Further kinetic studies on the inhibition of fibrinolysis by synthetic inhibitors.
    Iwamoto M; Abiko Y
    J Biochem; 1969 May; 65(5):821-3. PubMed ID: 4241157
    [No Abstract]   [Full Text] [Related]  

  • 19. [The synthesis of 4'-(2-carboxyethyl)phenyl trans-4-aminomethyl cyclohexane carboxylate hydrochloride (cetraxate hydrochloride) by means of enzymatic debenzylation].
    Kuroda H; Miyadera A; Kaneuchi T; Imura A
    Yakugaku Zasshi; 1989 Mar; 109(3):157-62. PubMed ID: 2754616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical control of hyperfibrinolytic states by synthetic inhibitors of fibrinolytic enzymes.
    Markwardt F; Klöcking HP
    Biomed Biochim Acta; 1983; 42(6):725-30. PubMed ID: 6605748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.